395 related articles for article (PubMed ID: 10657670)
1. Engagement of the OX-40 receptor in vivo enhances antitumor immunity.
Weinberg AD; Rivera MM; Prell R; Morris A; Ramstad T; Vetto JT; Urba WJ; Alvord G; Bunce C; Shields J
J Immunol; 2000 Feb; 164(4):2160-9. PubMed ID: 10657670
[TBL] [Abstract][Full Text] [Related]
2. Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor.
Kjaergaard J; Peng L; Cohen PA; Drazba JA; Weinberg AD; Shu S
J Immunol; 2001 Dec; 167(11):6669-77. PubMed ID: 11714839
[TBL] [Abstract][Full Text] [Related]
3. Induction of anti-mammary cancer immunity by engaging the OX-40 receptor in vivo.
Morris A; Vetto JT; Ramstad T; Funatake CJ; Choolun E; Entwisle C; Weinberg AD
Breast Cancer Res Treat; 2001 May; 67(1):71-80. PubMed ID: 11518468
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.
Kjaergaard J; Tanaka J; Kim JA; Rothchild K; Weinberg A; Shu S
Cancer Res; 2000 Oct; 60(19):5514-21. PubMed ID: 11034096
[TBL] [Abstract][Full Text] [Related]
5. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.
Weinberg AD; Wegmann KW; Funatake C; Whitham RH
J Immunol; 1999 Feb; 162(3):1818-26. PubMed ID: 9973447
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of primary breast tumors and tumor-draining lymph nodes by means of the T-cell costimulatory molecule OX-40.
Ramstad T; Lawnicki L; Vetto J; Weinberg A
Am J Surg; 2000 May; 179(5):400-6. PubMed ID: 10930490
[TBL] [Abstract][Full Text] [Related]
7. OX-40: life beyond the effector T cell stage.
Weinberg AD; Vella AT; Croft M
Semin Immunol; 1998 Dec; 10(6):471-80. PubMed ID: 9826580
[TBL] [Abstract][Full Text] [Related]
8. Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.
Evans DE; Prell RA; Thalhofer CJ; Hurwitz AA; Weinberg AD
J Immunol; 2001 Dec; 167(12):6804-11. PubMed ID: 11739496
[TBL] [Abstract][Full Text] [Related]
9. Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134).
Petty JK; He K; Corless CL; Vetto JT; Weinberg AD
Am J Surg; 2002 May; 183(5):512-8. PubMed ID: 12034383
[TBL] [Abstract][Full Text] [Related]
10. The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells.
Kaleeba JA; Offner H; Vandenbark AA; Lublinski A; Weinberg AD
Int Immunol; 1998 Apr; 10(4):453-61. PubMed ID: 9620601
[TBL] [Abstract][Full Text] [Related]
11. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.
Maxwell JR; Weinberg A; Prell RA; Vella AT
J Immunol; 2000 Jan; 164(1):107-12. PubMed ID: 10605000
[TBL] [Abstract][Full Text] [Related]
12. Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers.
Vetto JT; Lum S; Morris A; Sicotte M; Davis J; Lemon M; Weinberg A
Am J Surg; 1997 Sep; 174(3):258-65. PubMed ID: 9324133
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination.
Kuriyama H; Watanabe S; Kjaergaard J; Tamai H; Zheng R; Weinberg AD; Hu HM; Cohen PA; Plautz GE; Shu S
Cell Immunol; 2006 Sep; 243(1):30-40. PubMed ID: 17207783
[TBL] [Abstract][Full Text] [Related]
14. OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia.
Humphreys IR; Edwards L; Walzl G; Rae AJ; Dougan G; Hill S; Hussell T
J Immunol; 2003 Jun; 170(12):6125-32. PubMed ID: 12794142
[TBL] [Abstract][Full Text] [Related]
15. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles.
Brocker T; Gulbranson-Judge A; Flynn S; Riedinger M; Raykundalia C; Lane P
Eur J Immunol; 1999 May; 29(5):1610-6. PubMed ID: 10359115
[TBL] [Abstract][Full Text] [Related]
16. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses.
Morimoto S; Kanno Y; Tanaka Y; Tokano Y; Hashimoto H; Jacquot S; Morimoto C; Schlossman SF; Yagita H; Okumura K; Kobata T
J Immunol; 2000 Apr; 164(8):4097-104. PubMed ID: 10754303
[TBL] [Abstract][Full Text] [Related]
17. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
[TBL] [Abstract][Full Text] [Related]
18. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
[TBL] [Abstract][Full Text] [Related]
19. Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis.
Weinberg AD; Bourdette DN; Sullivan TJ; Lemon M; Wallin JJ; Maziarz R; Davey M; Palida F; Godfrey W; Engleman E; Fulton RJ; Offner H; Vandenbark AA
Nat Med; 1996 Feb; 2(2):183-9. PubMed ID: 8574963
[TBL] [Abstract][Full Text] [Related]
20. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
